236 related articles for article (PubMed ID: 26468984)
81. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
82. MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2.
Xu X; Zou H; Luo L; Wang X; Wang G
FEBS Open Bio; 2019 Oct; 9(10):1784-1797. PubMed ID: 31408273
[TBL] [Abstract][Full Text] [Related]
83. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
84. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
[TBL] [Abstract][Full Text] [Related]
85. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
Hu Z; Wang P; Lin J; Zheng X; Yang F; Zhang G; Chen D; Xie J; Gao Z; Peng L; Xie C
Cell Physiol Biochem; 2018; 51(1):470-486. PubMed ID: 30453289
[TBL] [Abstract][Full Text] [Related]
86. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
87. DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition.
Chandrakesan P; Weygant N; May R; Qu D; Chinthalapally HR; Sureban SM; Ali N; Lightfoot SA; Umar S; Houchen CW
Oncotarget; 2014 Oct; 5(19):9269-80. PubMed ID: 25211188
[TBL] [Abstract][Full Text] [Related]
88. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
89. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
90. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
Carcinogenesis; 2012 May; 33(5):1113-20. PubMed ID: 22362728
[TBL] [Abstract][Full Text] [Related]
91. Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation.
Khodadadi Kohlan A; Saidijam M; Amini R; Samadi P; Najafi R
Life Sci; 2019 Jul; 228():221-227. PubMed ID: 31075231
[TBL] [Abstract][Full Text] [Related]
92. Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4.
Li Q; Song W; Wang W; Yao S; Tian C; Cai X; Wang L
Oncotarget; 2016 May; 7(20):29749-60. PubMed ID: 27102441
[TBL] [Abstract][Full Text] [Related]
93. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
94. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
[TBL] [Abstract][Full Text] [Related]
95. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
96. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
97. Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer.
Luna JM; Barajas JM; Teng KY; Sun HL; Moore MJ; Rice CM; Darnell RB; Ghoshal K
Mol Cell; 2017 Aug; 67(3):400-410.e7. PubMed ID: 28735896
[TBL] [Abstract][Full Text] [Related]
98. HIPK3 Circular RNA Promotes Metastases of HCC Through Sponging miR-338-3p to Induce ZEB2 Expression.
Li W; Xue H; Li Y; Li P; Ma F; Liu M; Kong S
Dig Dis Sci; 2021 Oct; 66(10):3439-3447. PubMed ID: 33247421
[TBL] [Abstract][Full Text] [Related]
99. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.
Li Q; Gao Y; Jia Z; Mishra L; Guo K; Li Z; Le X; Wei D; Huang S; Xie K
Gastroenterology; 2012 Sep; 143(3):799-810.e2. PubMed ID: 22677193
[TBL] [Abstract][Full Text] [Related]
100. Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer.
Ji D; Zhan T; Li M; Yao Y; Jia J; Yi H; Qiao M; Xia J; Zhang Z; Ding H; Song C; Han Y; Gu J
Stem Cell Reports; 2018 Dec; 11(6):1506-1522. PubMed ID: 30449704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]